Glofit-GemOx: a new treatment paradigm in relapsed or refractory diffuse large B-cell lymphoma?

被引：0
|
作者：
Sureda, Anna [1 ]
Pavlosky, Astrid [2 ,3 ]
机构：
[1] Univ Barcelona, Inst Catala Oncol LHosp, Clin Haematol Dept, IDIBELL, Barcelona 08908, Spain
[2] Pavlovsky Ctr, Buenos Aires, Argentina
[3] Fundaleu, Haematol Dept, Buenos Aires, Argentina
来源：
LANCET | 2024年 / 404卷 / 10466期
关键词：
D O I：
10.1016/S0140-6736(24)02138-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1899 / 1901
页数：3
相关论文
共 50 条
  • [41] Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma
    Frontzek, Fabian
    Karsten, Imke
    Schmitz, Norbert
    Lenz, Georg
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [42] Emerging therapies for the treatment of relapsed or refractory diffuse large B cell lymphoma
    Skrabek, R.
    Assouline, S.
    Christofides, A.
    MacDonald, D.
    Prica, A.
    Sangha, R.
    Matthews, B. A.
    Sehn, L. H.
    CURRENT ONCOLOGY, 2019, 26 (04) : 253 - 265
  • [43] Management of Relapsed Diffuse Large B-cell Lymphoma
    Crump, Michael
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (06) : 1195 - +
  • [44] Management of Relapsed Diffuse Large B-Cell Lymphoma
    Kenkre, Vaishalee Padgaonkar
    Smith, Sonali M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (05) : 393 - 403
  • [45] Loncastuximab tesirine for treatment of relapsed or refractory diffuse large B cell lymphoma
    Goparaju, Krishna
    Caimi, Paolo F.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (11) : 1373 - 1381
  • [46] Management of relapsed diffuse large B-cell lymphoma
    Vaishalee Padgaonkar Kenkre
    Sonali M. Smith
    Current Oncology Reports, 2008, 10 : 393 - 403
  • [47] Relapsed/Refractory Diffuse Large B-cell Lymphoma: On the Threshold of New Therapies the Sud article reviewed
    Sud, Rohit
    Friedberg, Jonathan W.
    ONCOLOGY-NEW YORK, 2009, 23 (07): : 615 - 619
  • [48] Selinexor for relapsed or refractory diffuse large B-cell lymphoma: examining the artifact Reply
    Kalakonda, Nagesh
    Kauffman, Michael
    Shah, Jatin
    LANCET HAEMATOLOGY, 2020, 7 (10): : E707 - E708
  • [49] Glofitamab in Relapsed Refractory Diffuse Large B-Cell Lymphoma: Single Center Experience
    Yaman, Samet
    Candir, Burcu Aslan
    Bozan, Ersin
    Dal, Mehmet Sinan
    Altuntas, Fevzi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S445 - S445
  • [50] Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Lee, Boram
    Lee, Hyunwoo
    Cho, Junhun
    Yoon, Sang Eun
    Kim, Seok Jin
    Park, Woong-Yang
    Kim, Won Seog
    Ko, Young Hyeh
    FRONTIERS IN ONCOLOGY, 2021, 11
12345